Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04534569|
Recruitment Status : Completed
First Posted : September 1, 2020
Last Update Posted : October 8, 2020
|Condition or disease||Intervention/treatment|
|Covid19 Acute Respiratory Failure Acute Respiratory Distress Syndrome||Other: Experts consensus|
The investigators aim to achieve experts consensus on respiratory interventions in management of COVID-19 related acute respiratory failure (C-ARF). The pandemic of COVID-19 is unique in terms of a multitude of patients suffering from ARF and requiring invasive mechanical ventilation with single underlying inciting etiology.The experts have given divergent opinions on respiratory support of C-ARF which may have confused physicians globally.
The investigators are going to use a modified Delphi based methodology involving global participating experts. The objective is to achieve consensus statement on the management of C-ARF using "collective intelligence".
The whole process of this study will be done in the form of two-three rounds of Google Forms-based Delphi surveys. In this survey questionnaire, the investigators have prepared statements on the concern areas in the respiratory support of C-ARF. The survey has been divided into five sections related to C-ARF management. The majority of these statements are to be rated on Likert scale and others have multiple choices. There is an option for collecting participating experts comments in provided open space in round one which will be considered during round two questionnaire.
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) Using Modified Delphi Methodology|
|Actual Study Start Date :||September 4, 2020|
|Actual Primary Completion Date :||October 3, 2020|
|Actual Study Completion Date :||October 6, 2020|
- Other: Experts consensus
Consensus opinion using Delphi Methodology
- Consensus using participating experts opinions. [ Time Frame: 20 days ]Survey Questionnaire containing seven point Likert scale and multiple choice questions.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04534569
|United Arab Emirates|
|NMC Specialty Hospital|
|Dubai, United Arab Emirates, 7832|